Hong Kong stock fluctuation | Fosun Pharma (02696.HK) rises by over 5% again. H drug Hanshi enters the Indian market and HLX14 previously received positive evaluation comments from EMA.

According to the Citic Securities APP, Fuhong Hanlin (02696.HK) has risen by more than 5% again, as of the time of publication, it has risen by 5.28%, reaching 70.8 Hong Kong dollars, with a turnover of 151.565 million Hong Kong dollars.